
BGI Genomics Co., Ltd.
SZSE:300676.SZ
46.6 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||
Current Assets: | |||||||||||||
Cash & Cash Equivalents
| 3,934.561 | 4,732.376 | 5,157.744 | 6,590.287 | 5,430.072 | 735.327 | 1,070.061 | 946.645 | 748.643 | 516.41 | 508.247 | 320.826 | 352.909 |
Short Term Investments
| 375.116 | 753.575 | 1,231.947 | 2,049.07 | -116.101 | 482.22 | -71.272 | -76.21 | -74.141 | -49.623 | -37.116 | -34.905 | -24.526 |
Cash and Short Term Investments
| 4,309.677 | 5,485.951 | 6,389.691 | 8,639.357 | 5,430.072 | 1,217.547 | 1,070.061 | 946.645 | 748.643 | 516.41 | 508.247 | 320.826 | 352.909 |
Net Receivables
| 1,752.423 | 1,517.89 | 2,222.587 | 1,244.173 | 1,575.737 | 1,232.429 | 1,218.523 | 842.976 | 612.286 | 497.831 | 328.901 | 225.158 | 100.006 |
Inventory
| 601.62 | 602.182 | 717.833 | 877.719 | 1,009.819 | 342.972 | 241.906 | 138.582 | 73.594 | 111.401 | 87.061 | 67.388 | 30.486 |
Other Current Assets
| 212.071 | 326.77 | 268.202 | 273.511 | 520.373 | 307.332 | 784.334 | 1,903.87 | 1,756.052 | 1,921.389 | 320.116 | 288.454 | 332.915 |
Total Current Assets
| 6,875.791 | 7,932.793 | 9,765.736 | 11,034.76 | 8,416.943 | 3,203.507 | 3,281.881 | 3,832.073 | 3,202.342 | 3,047.03 | 1,213.88 | 891.946 | 812.601 |
Non-Current Assets: | |||||||||||||
Property, Plant & Equipment, Net
| 2,854.19 | 3,190.423 | 2,190.355 | 1,399.695 | 1,287.388 | 1,310.585 | 1,152.522 | 739.439 | 556.64 | 430.693 | 407.524 | 276.946 | 135.809 |
Goodwill
| 36.474 | 47.109 | 47.109 | 47.109 | 47.109 | 47.109 | 47.109 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 508.308 | 579.938 | 528.954 | 323.211 | 179.369 | 177.805 | 160.424 | 160.143 | 171.666 | 189.236 | 203.254 | 213.037 | 0.121 |
Goodwill and Intangible Assets
| 544.782 | 627.048 | 576.063 | 370.321 | 226.478 | 224.915 | 207.533 | 160.143 | 171.666 | 189.236 | 203.254 | 213.037 | 0.121 |
Long Term Investments
| 931.361 | 498.682 | 96.416 | -1,150.859 | 865.416 | 130.867 | 349.887 | 293.959 | 174.327 | 75.255 | 63.081 | 35.405 | 24.626 |
Tax Assets
| 230.47 | 241.579 | 236.293 | 200.286 | 162.055 | 93.542 | 71.245 | 48.83 | 38.453 | 38.774 | 49.885 | 49.061 | 29.746 |
Other Non-Current Assets
| 1,105.692 | 1,122.482 | 1,510.65 | 2,399.826 | 236.76 | 945.702 | 188.332 | 37.37 | 86.667 | 129.868 | 111.285 | 31.007 | 0.774 |
Total Non-Current Assets
| 5,666.495 | 5,680.215 | 4,609.778 | 3,219.27 | 2,778.098 | 2,705.611 | 1,969.52 | 1,279.74 | 1,027.753 | 863.827 | 835.028 | 605.456 | 191.076 |
Total Assets
| 12,542.286 | 13,613.008 | 14,375.514 | 14,254.03 | 11,195.041 | 5,909.118 | 5,251.4 | 5,111.813 | 4,230.094 | 3,910.857 | 2,048.908 | 1,497.402 | 1,003.677 |
Liabilities & Equity: | |||||||||||||
Current Liabilities: | |||||||||||||
Account Payables
| 78.176 | 864.595 | 1,024.868 | 805.322 | 873.231 | 221.156 | 139.034 | 119.658 | 57.924 | 46.798 | 45.18 | 55.251 | 37.775 |
Short Term Debt
| 24.912 | 24.184 | 0 | 5.006 | 563.296 | 0 | 0 | 8 | 3 | 8.129 | 7.31 | 2.45 | 0.9 |
Tax Payables
| 34.278 | 86.816 | 125.265 | 233.366 | 296.578 | 54.773 | 66.833 | 43.375 | 36.224 | 42.341 | 26.636 | 27.772 | 15.203 |
Deferred Revenue
| 0 | 0 | 928.623 | 2,402.595 | 2,248.689 | 350.162 | 66.833 | 257.533 | 222.309 | 172.922 | 127.819 | 435.783 | 453.124 |
Other Current Liabilities
| 2,704.508 | 2,321.444 | 2,805.665 | 930.299 | 1,271.71 | 858.569 | 738.445 | 642.049 | 634.331 | 590.128 | 451.922 | 775.247 | 778.993 |
Total Current Liabilities
| 2,841.874 | 3,297.04 | 3,943.939 | 3,383.517 | 3,802.121 | 1,134.498 | 944.313 | 813.082 | 731.48 | 687.397 | 531.047 | 860.719 | 832.871 |
Non-Current Liabilities: | |||||||||||||
Long Term Debt
| 388.81 | 283.427 | 136.68 | 716.403 | 801.941 | 235.557 | 0 | 0 | 0 | 0 | 1.928 | 0 | 0 |
Deferred Revenue Non-Current
| 15.106 | 0 | 19.675 | 36.074 | 49.101 | 46.024 | 33.024 | 31.124 | 42.759 | 47.808 | 42.321 | 27.229 | 14.259 |
Deferred Tax Liabilities Non-Current
| 24.887 | 13.127 | 51.562 | 5.191 | 1.479 | 26.17 | 6.703 | 9.672 | 3.282 | 6.165 | 8.106 | 11.509 | 6.176 |
Other Non-Current Liabilities
| 0 | 15.393 | 0 | 671.572 | 625.571 | 65.831 | 15 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 428.803 | 311.947 | 207.918 | 1,429.24 | 1,367.178 | 373.581 | 54.727 | 40.796 | 46.041 | 53.973 | 52.355 | 38.738 | 20.436 |
Total Liabilities
| 3,270.677 | 3,608.988 | 4,151.857 | 4,812.756 | 5,169.3 | 1,508.079 | 999.04 | 853.878 | 777.521 | 741.37 | 583.402 | 899.457 | 853.307 |
Equity: | |||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.496 | 1.06 | 0 |
Common Stock
| 415.822 | 413.914 | 413.914 | 413.914 | 400.1 | 400.1 | 400.1 | 400.1 | 360 | 360 | 85.859 | 20 | 2 |
Retained Earnings
| 3,673.712 | 4,617.985 | 4,941.366 | 4,318.698 | 3,020.478 | 974.197 | 861.887 | 703.511 | 428.887 | 182.325 | -40.159 | 47.153 | 56.313 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 478.251 | 340.759 | 199.227 | 343.019 | 311.152 | 448.28 | 2,570.875 | 2,552.693 | -2.496 | -1.06 | 0 |
Other Total Stockholders Equity
| 5,045.324 | 4,827.339 | 4,723.288 | 4,738.362 | 2,489.527 | 2,596.733 | 3,021.715 | 3,045.013 | 2,570.875 | 2,552.693 | 1,142.742 | 333.844 | 54.931 |
Total Shareholders Equity
| 9,134.857 | 9,859.238 | 10,078.568 | 9,318.408 | 5,910.105 | 4,314.049 | 4,164.96 | 4,148.625 | 3,359.762 | 3,095.018 | 1,185.946 | 399.936 | 113.244 |
Total Equity
| 9,271.61 | 10,004.02 | 10,223.657 | 9,441.273 | 6,025.741 | 4,401.039 | 4,252.36 | 4,257.935 | 3,452.573 | 3,169.487 | 1,465.506 | 597.945 | 150.371 |
Total Liabilities & Shareholders Equity
| 12,542.286 | 13,613.008 | 14,375.514 | 14,254.03 | 11,195.041 | 5,909.118 | 5,251.4 | 5,111.813 | 4,230.094 | 3,910.857 | 2,048.908 | 1,497.402 | 1,003.677 |